PPIDT00044

Drug Information
NameCetrorelix
SequenceNot Available
DrugBank_IDDB00050
Typesmall molecule
IndicationFor the inhibition of premature LH surges in women undergoing controlled ovarian stimulation

Dosage Forms
Form Route Strength
Powder —
0.25 mg
Injection, powder, for solution; kit Subcutaneous
0.25 mg/1mL
Kit Subcutaneous
0.25 mg/2mL
Injection, powder, for solution Subcutaneous
0.25 mg/ml
Injection, powder, lyophilized, for solution Subcutaneous
3 mg
Kit Subcutaneous
0.25 mg/1mL
Kit Subcutaneous
3 mg/3mL
Powder, for solution Subcutaneous
0.25 mg / vial
Powder, for solution Subcutaneous
3 mg / vial
Injection, powder, for solution Subcutaneous
0.25 mg
Injection Subcutaneous
0.25 MG
Injection, powder, lyophilized, for solution Subcutaneous
300000 mg
Injection, powder, lyophilized, for solution Subcutaneous
0.25 mg
Injection, solution —
0.25 MG
Powder —
0.25 mg/1vial
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P30968 GNRHR Gonadotropin-releasing hormone receptor Homo sapiens antagonist Link
target P22888 LHCGR Lutropin-choriogonadotropic hormone receptor Homo sapiens unknown Link